SCHEMBL7705461

SCHEMBL7705461

CC(Cc1c(Cl)cc(N)cc1Cl)c1nc(-c2ccccc2)cs1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.43
MEN1 O00255 5/20 0.41
KMT2A Q03164 5/20 0.41
NPC1 O15118 3/20 0.41
RAB9A P51151 3/20 0.41
MAPT P10636 3/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
LMNA P02545 2/20 0.41
KDM4E B2RXH2 1/20 0.41
NFKB1 P19838 1/20 0.41
NFKB2 Q00653 1/20 0.41
RELA Q04206 1/20 0.41
CYP3A4 P08684 1/20 0.41
LOXL2 Q9Y4K0 1/20 0.38
TSHR P16473 1/20 0.37
RECQL P46063 1/20 0.37
TAAR1 Q96RJ0 1/20 0.37
LTA4H P09960 1/20 0.37
SREBF2 Q12772 2/20 0.37
POLB P06746 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7888537 0.81 MEN1 (0.49) ALDH1A1MEN1KMT2ANPC1RAB9A
SCHEMBL7705459 0.79 LOXL2 (0.48) ALDH1A1MEN1KMT2ANPC1RAB9A
SCHEMBL21784013 0.74 ALDH1A1 (0.49) ALDH1A1MEN1KMT2ANPC1RAB9A
SCHEMBL7887157 0.72 MRE11 (0.39) ALDH1A1MEN1KMT2AMAPTSMN1; SMN2
SCHEMBL4583617 0.71 ALDH1A1 (0.56) ALDH1A1MEN1KMT2ANPC1RAB9A
SCHEMBL2754043 0.70 ALDH1A1 (0.55) ALDH1A1MEN1KMT2ANPC1RAB9A
Hydrochloric Acid SCHEMBL7504446 0.70 ALDH1A1 (0.55) ALDH1A1MEN1KMT2ANPC1RAB9A
SCHEMBL6455740 0.68 ALDH1A1 (0.46) ALDH1A1MEN1KMT2ANPC1RAB9A
SCHEMBL10052165 0.68 KMT2A (0.58) ALDH1A1MEN1KMT2ANPC1RAB9A
SCHEMBL11697020 0.68 ALDH1A1 (0.52) ALDH1A1MEN1KMT2ANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020010177-A1 IL-5 inhibiting 6-azauracil derivatives JANSSEN CILAG S.A. (FR) 2002-01-24 US disclosed
EP-1114046-A1 INTERLEUKIN-5 INHIBITING 6-AZAURACIL DERIVATIVES Janssen Pharmaceutica N.V. (BE) 2001-07-11 EP disclosed
WO-2000017195-A1 INTERLEUKIN-5 INHIBITING 6-AZAURACIL DERIVATIVES JANSSEN PHARMACEUTICA N.V. (BE) 2000-03-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020010177-A1 IL-5 inhibiting 6-azauracil derivatives ALOX5, IL5, IL6ST ALDH1A1 1746/4885MEN1 4651/4885KMT2A 4018/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.